GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Mayo Clinic
Mayo Clinic
University Health Network, Toronto
University of Iowa
Swiss Cancer Institute
Medical College of Wisconsin
St. Jude Children's Research Hospital
Institut Bergonié
University of Calgary
Institut Bergonié
Roswell Park Cancer Institute
Mayo Clinic
Northwestern University
University of Maryland, Baltimore
Loma Linda University
St. Jude Children's Research Hospital
Ruijin Hospital
The Netherlands Cancer Institute
Radboud University Medical Center
Jonsson Comprehensive Cancer Center
Clinica Universidad de Navarra, Universidad de Navarra
Columbia University
Shanghai Zhongshan Hospital
Grupo Espanol de Investigacion en Sarcomas
Nanfang Hospital, Southern Medical University
Massachusetts General Hospital
University of Florida
RenJi Hospital
University of Alabama at Birmingham
Duke University
M.D. Anderson Cancer Center
Duke University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Duke University
Universitaire Ziekenhuizen KU Leuven